Vycor Medical, Inc.

VYCO

OTC

Healthcare

Medical - Devices

Boca Raton, FL, US7 employeesvycormedical.com

—

At a Glance

AI-generated

Vycor Medical navigated a challenging fiscal year 2025, achieving revenue growth and a return to positive operating income, yet persistent net losses and negative free cash flow underscore significant ongoing financial pressures.

Revenue breakdown: Vycor Medical Inc (95.9%), Nova Vision Inc (4.1%).

8-K

Vycor Medical reported annual revenue growth of 17% to $1.86 million for 2025, achieving an operating profit of $33,900 compared to a loss in 2024, driven by strong international sales of its neurosurgical device.

—

Market Cap

—

Revenue

—

Net Income

Employees7

Fundamentals

How The Business Makes Money

Revenue by Segment

Vycor Medical Inc95.9%($3M)

Nova Vision Inc4.1%($140.9K)

Revenue by Geography

US99.8%($3M)

Europe0.2%($8.6K)

Activity

What Changed Recently

Financial Results

Mar 30, 2026

of Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall they be deemed incorporated by referenc

Peer Companies

Company	Price	Change	Market Cap	P/E
CMPDCompuMed, Inc.	—	—	—	—
RMSLREMSleep Holdings, Inc.	—	—	—	—
RSCFReflect Scientific, Inc.	—	—	—	—
FNAMEvolutionary Genomics, In...	—	—	—	—
FZMDFuse Medical, Inc.	—	—	—	—
CLABFCore One Labs Inc.	—	—	—	—
LIFDLFTD Partners Inc.	—	—	—	—
HLYKHealthLynked Corp.	—	—	—	—

Company Profile

CIK0001424768

ISINUS92921M2035

CUSIP92921M203

Phone561 558 2000

Address951 Broken Sound Boulevard, Boca Raton, FL, 33487, US

SEC EDGAR